VCU Massey Cancer Center

Menu

2017 Archive

Sweet potato casserole

Recipe corner: sweet potato & green bean casseroles

Do rich casseroles have a place on your Thanksgiving dinner table? If so, consider adding a few more healthful side dishes to your menu mix to give guests some options. Instead of the traditional high calorie or high fat sweet potato and green bean casseroles, try these two updated recipes. Their fresh fruits and vegetables boost flavor, fiber and nutrition.

Continue reading →

Lulú De Panbehchi finds comfort in double mastectomy; glad there was a 'solution' after two separate breast cancer diagnoses

Maria “Lulú” De Panbehchi is one of six siblings and her mother is one of 11 siblings, with no previous family history of breast cancer. “I’m the only one. I won the lottery, the genetic lottery,” she said as she cracked a smile. “But I’m glad that it was me and not my sisters or my mother because I’m close to VCU Massey Cancer Center.”

Continue reading →

Working to reduce breast cancer risk through a diet and exercise program packaged and delivered through a mammography screening clinic

The average woman’s risk of developing breast cancer in the U.S. is one in eight. Efforts to address the risk and detection of breast cancer have focused primarily on mammography screening, with less emphasis on the preventive role of achieving and maintaining a healthy body weight through physical activity and diet.

Continue reading →

Massey researcher creates artificial molecules to target lung cancer mutations in hopes of developing novel treatments

Mario Acunzo, Ph.D., designs artificial molecules and uses them to target cancer-causing genetic mutations in hopes of developing new treatments for lung cancer and other forms of disease.

Continue reading →

This image shows autophagic vesicles containing mutant K-Ras formed in the membrane of human pancreatic cancer cells after exposure to neratinib.

Study finds newly approved breast cancer drug defeats the Ras genes notorious for causing many types of cancer

A new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.

Continue reading →